A new publication involving capromorelin appeared on March 9, 2026, in the American Journal of Veterinary Research. The article is titled "Validation of a flow cytometric competitive efflux assay for assessing clinically important drugs as canine P-glycoprotein substrates." The publication is listed under PubMed ID 41802412.
This publication describes work related to a flow cytometric competitive efflux assay used to assess clinically important drugs, including capromorelin, as substrates of canine P-glycoprotein. No findings, conclusions, or results beyond the title and publication details have been provided for this brief.
Readers interested in capromorelin can consult the compound overview for additional background and context.